13F

Stock

Acurx Pharmaceuticals, Inc.

ACXP · held by 18 managers

Reported value

$345.2K

Holders

18

+0 new · −0 exited

Holders’ est. mark

−$9.59K

Price effect on 2 books still in the name

Largest holder

$103.2K

MILLENNIUM MANAGEMENT LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MILLENNIUM MANAGEMENT LLC41.4K$103.2KHeld
Vanguard23.3K$58KHeld
Prospect Financial Services LLC19.8K$49.4KHeld
NORTHERN TRUST CORP16.9K$42.1KHeld
GEODE CAPITAL MANAGEMENT, LLC12.4K$30.9KHeld
JANE STREET GROUP, LLC10.7K$26.8KHeld
MORGAN STANLEY6.5K$16.2K−$9.56KCut−$6.59K
Tower Research Capital LLC (TRC)2.88K$7.18KHeld
WELLS FARGO & COMPANY/MN2.3K$5.73KHeld
NBC SECURITIES, INC.1.5K$3.73KHeld
GROUP ONE TRADING LLC283$705Held
Cornerstone Planning Group LLC167$433Held
UBS Group AG169$420Held
OSAIC HOLDINGS, INC.100$249Held
BlackRock, Inc.60$149Held
BANK OF AMERICA CORP /DE/17$42−$31Cut−$262
SBI Securities Co., Ltd.13$32Held
CITIGROUP INC1$2Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.